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Abstract
 The majority of deaths among cancer patients are attributed to the metastatic spread of cancer cells to vital organs 
instead of primary tumor outgrowth. Plus, cancer therapeutics which focusing on conventional chemotherapy is often 
toxic not only to tumor cells but also to normal cells and caused their therapeutic use is limited. In this review, aberrant 
glycosylation is proposed to be a method of cancer diagnosis in order to identify cancer at its earliest and more 
treatable stage. Aberrant glycosylation is a universal feature of cancer cells. Glycosylation, the attachment of sugar 
moieties to protein, is a major form of post-translational modifi cation (PTM) that is observed in approximately half of all 
proteins. Certain glycan structures are well known markers for tumor progression and its availability and composition 
in the microenvironment may affect glycosylation of the cell. In order to understand the biological application of simple 
sugars as anticancer agents, it is vital to fundamentally investigate the relationship between simple sugars and cell 
proliferation using living cell lines in vitro. Various simple sugars have been studied previously in a number of cancer 
cell lines representing different evolutionary stages of cancer. It has been examined that there is a selective effect of 
individual simple sugars on the pattern of growth and metabolism of certain cell lines in tissue culture. The results from 
previous studies reported that certain simple sugars were able to alter the growth pattern and morphology of several 
cancer cell lines which indicate that sugars have antiproliferative effect on cancer cells.
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Özet
 Kanser hastalarında ölümlerin çoğunluğu, kanser hücrelerinin primer tümör gelişimi yerine hayati organlara yayılımı ile 
ilgilidir. Ayrıca, konvansiyonel kemoterapiye odaklanan kanser tedavileri, genellikle sadece tümör hücreleri için değil 
aynı zamanda normal hücrelere toksiktir ve terapötik kullanımının neden olduğu sınırlıdır. Bu derlemede, anormal 
glikozilasyon, kanseri en erken ve tedavisi mümkün olan aşamada tanımlamak için bir kanser tanısı yöntemi olarak 
önerilmiştir. Aşikâr glikosilasyon, kanser hücrelerinin evrensel bir özelliğidir. Glikosilasyon, şekere yarımların proteine 
bağlanması, tüm proteinlerin yaklaşık yarısında gözlemlenen post translasyonel modifi kasyonun (PTM) önemli bir şek-
lidir. Belirli glikan yapıları, tümör ilerlemesi için iyi bilinen belirteçlerdir ve mikro ortamdaki mevcut durumu ve bileşimi 
hücrenin glıkosilasyonunu etkileyebilir. Basit şekerlerin kanser önleyici ajanlar olarak biyolojik olarak uygulanmasını 
anlamak için basit şekerler ile hücre proliferasyonu arasındaki ilişkiyi in vitro canlı hücre dizileri kullanarak araştırmak 
hayati önem taşımaktadır. Çeşitli basit şekerler daha önce kanserin farklı evrim safhalarını temsil eden bir dizi kanser 
hücre dizisinde incelenmiştir. Doku kültüründe bazı hücre çizgilerinin büyüme ve metabolizma modelleri üzerinde 
bireysel basit şekerlerin seçici bir etkisi olduğu incelenmiştir. Önceki çalışmaların sonuçları, bazı basit şekerlerin, şe-
kerlerin kanser hücreleri üzerinde antiproliferatif etkisi olduğuna işaret eden birkaç kanser hücre çizgisinin büyüme 
modelini ve morfolojisini değiştirebildiğini bildirmiştir.
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Introduction
To date, cancer patients are often diagnosed at advanced stages 
due to lack of distinct for early symptoms. There are patients with 
primary tumors that could be cured by surgical resection but for 
those who are in later stages, they receive chemotherapy and ra-
diotherapy for cancer treatment. However, the majority eventu-
ally succumb to metastases1. The majority of death among cancer 
patients are attributed to the metastatic spread of cancer cells to 
vital organs instead of primary tumor outgrowth2. Plus, cancer the-
rapeutics which focusing on conventional chemotherapy is often 
toxic not only to tumor cells but also to normal cells and caused 
their therapeutic use is limited. In regard to advance the current 
treatment of cancer, there is an increasing interest in developing 
an effective diagnostic method to inhibit proliferation and restrain 
the metastatic capability of cancer cells. In this review, aberrant 
glycosylation is proposed to be a method of cancer diagnosis in 
order to identify cancer at its earliest and more treatable stage. 
Thus, the underlying mechanisms and functions of sugars, pro-
teins and glycoproteins in cellular biological response have to be 
understood. In the first stage, we want to investigate the antipro-
liferative effects of simple sugars on different types of living cell 
lines in vitro and eventually to evaluate the anticancer potential 
of specific sugars on cancer cells. This review will highlight the 
current status of the use of simple sugars that are being evaluated 
as potential anticancer agents.
Abberant Glycosylatıon
Aberrant glycosylation is a universal feature of cancer cells3,4. 
Glycosylation, the attachment of sugar moieties to protein, is a 
major form of post-translational modification (PTM) that is obser-
ved in approximately half of all proteins5. Certain glycan structures 
are well known markers for tumor progression and its availability 
and composition in the microenvironment may affect glycosylati-
on of the cell. Tumor initiation and progression are associated with 
alterations in the structures of the glycan that is covalently attac-
hed to glycoproteins and glycolipids patterns at the cell surface3. 
Aberrant expression of glycan structures may affect ligand-recep-
tor interactions and thus interfere with regulation of cell adhesion, 
migration and proliferation6
.
Dietary sugars play a regulatory roles in enzymatic glycosylation 
reactions in human7. Sugars are the major source of metabolic 
energy in animal cells. Cells need carrier or transporter proteins 
for the introduction of sugars through their plasma membrane be-
cause of the hydrophilic nature of the cells8. Cancer cells are well 
known to display an enhanced sugar uptake and consumption. In 
fact, sugar transporters are deregulated in cancer cells thus they 
incorporate higher amount of sugar than normal cells. Previous 
in vitro studies have consistently reported that exogenous sugars 
would affect cell differentiation and cell-surface glycan structu-
res9,10,11. The ability to distinguish the differences in the glycosyla-
tion of proteins between cancer and control patients emphasizes 
glycobiology as a promising field to introduce new potential met-
hod for cancer diagnosis12. 
Latest Research Findings of Its Potentil 
In order to understand the biological application of simple sugars 
as anticancer agents, it is vital to fundamentally investigate the re-
lationship between simple sugars and cell proliferation using living 
cell lines in vitro. Various simple sugars have been studied previo-
usly in a number of cancer cell lines representing different evolu-
tionary stages of cancer. It has been examined that there is a se-
lective effect of individual simple sugars on the pattern of growth 
and metabolism of certain cell lines in tissue culture13,14,16,17,19. The 
addition of simple sugars to a certain cell lines can caused an al-
teration in the morphology of the cells, a change in the pattern of 
cell association and a decrease in the rate of cell growth13,14,16,17,19. 
Different specific sugars did not cause similar effects on the same 
cell line even with its closely related sugar. For example, L-fucose 
is able to alter the morphological characteristics of 3T3 mouse 
culture but not D-fucose although they are stereoisomers13. From 
here, it is found that the effect of specific simple sugar differs dis-
tinctly on different cell lines.
Fructose on MDA-MB-468 Human Breast Cancer Adenocarcino-
ma Cell Lines (Monzavi-Karbassi et al, 2010)14
This research demonstrated that substituting fructose for gluco-
se as the carbon source in cell culture media for MDA-MB-468 
human breast tumor cell line induces phenotypic changes which 
are associated with tumor progression and metastasis. The cell-
surface glycosylation phenotype was modified in cells grown in 
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glucose/fructose and fructose media where the cells displayed 
multiple changes in lectin binding compared to the cells grown 
in glucose media. These results suggested that adding fructose 
induced modification in carbohydrate epitopes. Alteration in 
glycan structures can affect proliferative, migratory, invasive and 
adhesive properties of tumor cells. The attachment of tumor cells 
to vascular endothelial cells is a main step in metastasis. Human 
umbilical vein endothelial cell (HUVEC) adhesion assay was done 
to examine the effect of carbon source and there was significantly 
increased binding when cells were grown at higher fructose con-
centration compared to glucose. The expression of sialylated 
structures was increased in fructose-treated cells. In this research, 
the Promega Cell Titer 96 Aqueous One Solution Cell Proliferation 
Assay was performed to study the cell growth of MDA-MB-468 
cell line treated with fructose, glucose and fructose/glucose. The 
solution combines PES, a chemically stable electron coupling re-
agent, and MTS, a novel tetrazolium compound that is soluble in 
tissue culture medium. From the results, it showed that growth 
rate of fructose-fed cells was significantly inhibited compared to 
glucose and glucose/fructose. However, the addition of fructose 
promoted the migratory ability of the cells where faster wound 
closure was seen and it was mostly due to an increase in cell mig-
ration and not cell proliferation. This cellular motility is an ex vivo 
measure for cell metastatic potential15. After being adapted with 
fructose, the tumor cells lose their epithelial features and took on a 
fibroblast-like shape. The cells displayed a more dispersed growth 
pattern than cell propagated in other media. There were distinctive 
changes in the shape of the cells if compared to the cells cultured 
in either glucose or glucose/fructose where they maintained their 
rounded, cluster conformation. Presence of fructose in the medi-
um also mediated tumor cell invasiveness. 
D-allose on HuH-7 human adenocarcinoma cancer cell lines 
(Yamaguchi et al., 2008)16
The effect of D-allose on the proliferation of cancer cells was 
examined in this study as well as the underlying molecular mec-
hanism of the action. The HuH-7 hepatocellular carcinoma cells 
were treated for 48 hours with various concentration of D-allose, 
D-psicose, D-glucose and D-fructose. Proliferation of the cells 
were measured by using MTT method and D-allose shown to in-
hibit cell growth by 40% in a dose-dependent manner. Meanw-
hile, other sugars did not show any growth inhibitory effect on 
the cells. Flow cytometric analysis was performed to examine the 
cell cycle of HuH-7 cells. D-allose significantly increased the per-
centage of cells in G1 phase and decreased the percentage in S 
phase. D-allose inhibited the HuH-7 cell growth by inducing the 
G1 cell cycle arrest but not apoptosis. D-allose was revealed to up-
regulated thioredoxin interacting protein (TXNIP) gene expression 
in the microarray analysis and from Western blot analysis, its inc-
rease at protein level was confirmed. The overexpression of TXNIP 
also induced G1 cell cycle arrest. p27kip1, a key regulator of G1/S 
cell cycle transition, showed to be increased at the protein but not 
the transcriptional level based on the analysis of cell cycle regula-
tory genes. Yamaguchi et al. (2008) suggested that D-allose may 
act as a novel anticancer agent via specific TXNIP induction and 
subsequent p27kip1 protein stabilization.
D-allose on HeLa, HepG2, HuH-7 cancer cell lines 
(Sui et al, 2005)17
 
D-allose was one of the rare sugars investigated by Sui et al. (2005) 
apart from D-psicose, D-allose, D-altrose and D-talitol. By the dis-
covery of Izomoring18, an effective strategy for mass production 
of rare sugars from inexpensive D-glucose and D-fructose has 
been developed to put an end to the laborious, time-consuming 
and inefficient chemical production of rare sugars. The research 
focused on the effect of rare sugars on the cell growth of HeLa 
(human cervical cancer), HepG2 (human hepatocarcinoma), HuH-
7 (human hepatocarcinoma) and immortalized cell line HaCaT (hu-
man skin keratinocyte) cell lines in vitro. The viability of the cells 
was evaluated by MTT assay after 24-, 48- and 72-h treatment. 
The result showed that D-allose had a significant inhibitory effect 
on cancer cell proliferation in a dose-dependent manner plus it 
was proportional to the length of treatment. Another rare sugar, 
D-altrose also showed a definite inhibitory effect in HeLa, HepG2 
and HaCaT cells. Cell cycle analysis by flow-cytometry, TUNEL as-
say and Western blot analysis were performed in HepG2 cells in 
order to understand the potential molecular mechanisms of the 
cell. After being treated with D-allose for 5 days, the accumulation 
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of cells in the G2/M phase was observed where the distribution of 
in G2/M phase cells was increased compared in control cultures. 
Morever, there were found decrement of S phase cells in D-allose-
treated cells if compared with control cells. In the TUNEL assay 
analysis, the percentage of apoptosis of D-allose-treated HepG2 
cells was increased significantly higher compared to untreated 
control HepG2 cells. These results proved that D-allose inhibits 
cell growth, and might correlate with the moderate G2/M arrest, 
modification of cell cycle regulatory proteins and induction of 
apoptosis.
D-Glucosamine on Ascites Tumor Cells (Bekesi et al, 1969)19
 
Bekesi et al (1969) reported that incubation in vitro with 
D-glucosamine showed an inhibitory effect on Sarcoma 37, and 
Sarcoma 180 ascites tumors and Ehrlich ascites carcinoma cells. 
The cells viability was examined by the trypan blue staining met-
hod, where only unstained cell were considered viable. The viabi-
lity of the control Ehrlich ascites cells incubated in Krebs-Ringer 
phosphate buffer (containing glucose or pyruvic acid, but no glu-
cosamine) was maintained. However, incubation of the three as-
cites tumor cells lines in the same buffer system with addition of 
D-glucosamine resulted in rapid loss of viability and after 5 hours 
less than 5% of the cell population was unstained. It was apparent 
that all the cell lines were equally susceptible to the treatment of 
glucosamine. The effect of 19 different sugars were also been stu-
died in this research on the viability of Sarcoma 180 ascites tumor 
cells with addition of same concentration for each sugar. Based on 
the results, D-mannose was the only neutral sugar that showing 
a powerful cytotoxic effect and caused the loss of viability of the 
cells although it was presumed that exogenous D-mannose, like 
D-glucose and D-fructose which can be utilized by the cells20. It 
was also reported that the loss of viability of the ascites tumor cells 
was progressively decreased with the increasing concentration of 
D-mannose added in the incubation media. However, after being 
tested with L-mannose, the cells only showed a minor change in 
the viability which proved the specificity of the sugar treatment. 
Other than D-mannose, nanoacetylated amino sugars such as 
D-glucosamine, D-mannosamine and D-galactosamine also sho-
wed inhibitory effects on the tumor growth.
L-fucose and D-mannose on 3T3 mouse fibroblast and BS-C-1 
monkey kidney cell line (Cox, et al. 1965)13
 
In this research study, the sugars that were used for treatment 
were D-glucose, D-galactose, D-mannose, L-fucose, N-acetyl-
D-glucosamine, N-acetyl-D-galactosamine and N-acetyl-D-
mannosamine. The cellular morphology of three types of mouse 
lines were examined daily for any alteration, cell detachment from 
the surface, growth pattern and tendency for the cultures to be-
come confluent and overlap. L-fucose was the only sugar which 
appeared to alter the cells morphology and the growth pattern 
for all three mouse lines. The most striking effect was observed 
on 3T3 embryonic mouse fibroblast as the culture did not achi-
eve confluent pattern with less dividing cells. The morphology 
of the cells were also altered to be more spindle-shaped. Similar 
but less striking effect was seen in cultures of 3T3 primary mouse 
embryo fibroblast. On the other hand, effect of L-fucose on the 
embryonic mouse line 3T6 was minimal if compared to the two 
types of cells stated before, where the cells exhibited little contact 
inhibition and formed a multilayered cell sheet in the culture. On 
top of that, D-mannose also appeared to inhibit the proliferation 
of African green monkey kidney cell line (BS-C-1), three types of 
human skin fibroblast and also heteroploid epithelial human cell 
line (HeLa Ch). The cells became less confluent and exhibit less 
cell overlapping. The morphology of the cells were also altered in 
response to D-mannose except for HeLa cell line. The cells viability 
after treated with sugars at 48-72 hour was calculated by the total 
cell protein per bottle. For 3T3 cultures and BS-C-1 green mon-
key kidney cell cultures, L-fucose and D-mannose were the only 
sugars that able to reduce the growth rate of the cells respectively. 
Even the mechanism of this effect was not clear, they suggested 
that L-fucose and D-mannose may alter the morphology of the 
cells by binding to specific sites on the cell surface.
Conclusion 
The results from previous studies reported that certain simple 
sugars were able to alter the growth pattern and morphology of 
several cancer cell lines which indicate that sugars have antip-
roliferative effect on cancer cells. However, all cell lines did not 
respond in the same way. The mechanism which account for the 
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specificity of the sugar reactions are still unclear. However, it is the 
most intriguing aspect of the modification observed. It may seems 
possible that certain sugars interfere directly with the intermedi-
ary metabolism of some cell lines but not others. It is implausible 
since most mammalian cell lines have similar metabolic pathways 
and nutritional demands. An alternative yet attractive explanation 
is that the specificity of the effects is due to binding of the sugars 
with complementary sites on the cell surface leading to subsequ-
ent morphologic and metabolic changes. Many cell functions are 
arbitrated by the sugar moieties present on the cell surface and 
that addition and treatment of sugar to the culture medium speci-
fically alters some of these functions.
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Table 1 : Overview of sugar studies on antiproliferative effect in vitro
Type of Sugars Type of Cells Method Outcome Reference
• Glucose
• Glucose + fructose
• Fructose
MDA-MB-468 (human breast adeno-
carcinoma)
Cell Titer 96 Aqueous 
One Solution Proliferation 
Assay (ELISA reader)
Addition of fructose inhibits higher rate of cellular 
proliferation compared to glucose and glucose/
fructose.
Monzavi-Karbas-
si et al (2010)
• D-allose
• D-psicose
• D-glucose
• D-fructose
HuH-7 (human hepatocarcinoma)
MTT assay
Flow cytometric analysys
cDNA microarray analysis
RTqPCR
Western blot and immu-
noprecipitation analysis
D-allose inhibit cell growth in a dose dependent 
manner but not other sugars
D-allose induced G1 cell cycle arrest
D-allose inhibit the cell growth by specific TXNIP 
induction and p27kip1 protein stabilization
Yamaguchi et al 
(2008)
• D-psicose
• D-allose
• D-altrose
• D-talitol
HeLa (human cervical cancer)
HuH-7 (human hepatocarcinoma)
HepG2 (human hepatocarcinoma)
HaCaT (human skin keratinocyte)
MTT assay
Flow cytometric analysis
Western Blot analysis
   
TUNEL assay
D-allose inhibits the proliferation of cells in a dose 
and time dependent manner.
D-altrose also showed a definite inhibitory effect 
on cells.
D-allose increased G2/M phase distribution and 
also decreased S phase population in HepG2 cells.
Significant increment in percentage of apoptosis of 
D-allose-treated HepG2.
Li Sui et al 
(2005)
• D-glucosamine
• N-acetylglucosamine
• D-mannosamine
• N-acetylmannosamine
• D-galactosamine
• N-acetylgalactosamine
• D-glucose
• Α-methyl-D-glucoside
• 2-deoxy-D-glucose
• D-galactose
• D-fructose
• D-mannose
• L-Mannose
• D-fucose
• L-fucose
• L-rhamnose
• -D-ribose
• D-xylose
• L-arabinose
Sarcoma 37  ascites tumor cells
Sarcoma 180 ascites tumor cells
Ehrlich  ascites tumor cells
Trypan blue staining 
method
D-glucosamine and D-mannose reduce viable cell 
after incubation in dose-dependent manner
Bekesi et al 
(1969)
• D-glucose
• D-galactose
• L-fucose
• D-fucose
• D-mannose
• N-acetyl-D-glucosamine
• N-acetyl-D-galactosamine
• N-acetyl-D-mannosamine
3T3 (Heteroploid Embryonic Mouse 
Fibroblasts)
3T3 (Primary Mouse Fibroblast)
3T6 (Embryonic Mouse Line)
BS-C-1 (African green monkey kidney 
cell line)
Human skin fibroblast
HeLa Ch (heteroploid epithelial human 
cell line)
Total cell protein meas-
urement per bottle
Protein and radioactivity 
assay
3T3 cells grown in L-fucose had a slow growth 
while cells grown in medium supplemented with 
equal amounts of the other sugars became conflu-
ent.
D-mannose inhibit the growth rate of BS-C-1, hu-
man skin fibroblast and HeLa cells.
Cox & Gesner 
(1967)
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